BFRI 1 (-3.85%)
US09077D1000Drug ManufacturersDrug Manufacturers - Specialty & Generic

Biofrontera (BFRI) Competitor Comparison

We are evaluating the key criteria listed to compare Biofrontera (BFRI) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Earnings per Share - BFRI ranking 51 / 54

These are the competitors of Biofrontera in the industry Drug Manufacturers - Specialty & Generic ranked by earnings per share
1. Linc LNC
7.38
2. Zoetis ZTS
5.18
3. Amphastar Pharmaceuticals AMPH
2.91
4. Collegium Pharmaceutical COLL
2.51
5. SCYNEXIS SCYX
2.11
6. ANI Pharmaceuticals ANIP
1.61
7. Pacira BioSciences PCRX
1.51
8. Taro Pharmaceutical Industries TARO
1.43
9. Embecta EMBC
1.22
10. Eagle Pharmaceuticals EGRX
0.85
11. Procaps Group PROC
0.51
12. Vifor Pharma G2AB.F
0.46
13. Phibro Animal Health PAHC
0.33
14. Kamada KMDA
0.23
15. PetIQ PETQ
0.23
16. Green Thumb Industries R9U2.F
0.22
17. Kolinpharma KIP.MI
0.21
18. Organogenesis Holdings ORGO
0.04
19. Perrigo PRGO
0.01
20. Cronos Group CRON
-0.14
21. Societal CDMO SCTL
-0.14
22. Journey Medical DERM
-0.17
23. Ascend Wellness Holdings AAWH
-0.23
24. Alimera Sciences ALIM
-0.25
25. Supernus Pharmaceuticals SUPN
-0.29
26. OptiNose OPTN
-0.31
27. Curaleaf Holdings CURLF
-0.33
28. Teva Pharmaceutical Industries TEVA
-0.42
29. Tilray Brands TLRY
-0.44
30. Regencell Bioscience Holdings RGC
-0.45
31. Theratechnologies THTX
-0.58
32. Jupiter Wellness JUPW
-0.59
33. Cumberland Pharmaceuticals CPIX
-0.59
34. Amneal Pharmaceuticals AMRX
-0.73
35. Zynerba Pharmaceuticals ZYNE
-0.85
36. Harrow Health HROW
-0.91
37. Evolus EOLS
-1.04
38. Alpha Teknova TKNO
-1.05
39. Bausch Health Companies BHC
-1.24
40. ProPhase Labs PRPH
-1.36
41. Universe Pharmaceuticals UPC
-1.7
42. Avadel Pharmaceuticals AVDL
-1.82
43. Ayr Wellness 3KJB.F
-1.95
44. Alvotech ALVO
-2.08
45. Elanco Animal Health ELAN
-2.65
46. Relmada Therapeutics RLMD
-3.13
47. Solid Biosciences SLDB
-3.93
48. Flora Growth FLGC
-6.24
49. Catalent CTLT
-6.48
50. Ironwood Pharmaceuticals IRWD
-6.78
51. Biofrontera BFRI
-10.3
52. Emergent BioSolutions EBS
-10.97
53. Neoleukin Therapeutics NLTX
-12.28
54. Clever Leaves Holdings CLVR
-12.63

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.